Literature DB >> 19264616

Molecular characterization of human rhinovirus field strains isolated during surveillance of enteroviruses.

Soile Blomqvist1, Carita Savolainen-Kopra1, Anja Paananen1, Tapani Hovi1, Merja Roivainen1.   

Abstract

Human rhinoviruses (HRVs), which are the most frequent causative agents of acute upper respiratory tract infections, are abundant worldwide. We have identified HRV strains in environmental specimens collected in Finland, Latvia and Slovakia during the surveillance of polio- and other enteroviruses. These acid-sensitive HRV strains were isolated under conditions optimized for growth of most of the enteroviruses, i.e. in stationary human rhabdomyosarcoma cells incubated at 36 degrees C. Phylogenetic analysis of the sequences derived from the partial 5' non-coding region and the capsid region coding for proteins VP4/VP2 and VP1 showed that the HRV field strains clustered together with prototype strains of the HRV minor receptor group. Partial sequences of the 3D polymerase coding region generally followed this pattern, with the exception of a set of three HRV field strains that formed a subcluster not close to any of the established HRV-A types, suggesting that recombination may have occurred during evolution of these HRV strains. Phylogenetic analysis of the VP4/VP2 capsid protein coding region showed that the 'environmental' HRV field strains were practically identical to HRV strains recently sequenced by others in Australia, the United States and Japan. Analysis of amino acids corresponding to the intercellular adhesion molecule-1 receptor footprint in major receptor group HRVs and also in the low-density lipoprotein receptor footprint of minor receptor group HRVs showed conservation of the 'minor receptor group-like' amino acids, indicating that the field strains may have maintained their minor receptor group specificity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264616     DOI: 10.1099/vir.0.008508-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

Review 1.  Microbe hunting.

Authors:  W Ian Lipkin
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

2.  Genus-specific substitution rate variability among picornaviruses.

Authors:  Allison L Hicks; Siobain Duffy
Journal:  J Virol       Date:  2011-05-25       Impact factor: 5.103

3.  Sequencing human rhinoviruses: direct sequencing versus plasmid cloning.

Authors:  Jodell E Linder; Tatyana E Plachco; Romina Libster; E Kathryn Miller
Journal:  J Virol Methods       Date:  2014-10-05       Impact factor: 2.014

4.  Retrospective Surveillance of Wastewater To Examine Seasonal Dynamics of Enterovirus Infections.

Authors:  Nichole E Brinkman; G Shay Fout; Scott P Keely
Journal:  mSphere       Date:  2017-06-14       Impact factor: 4.389

5.  Human rhinovirus C--associated severe pneumonia in a neonate.

Authors:  Eeva Broberg; Jussi Niemelä; Elina Lahti; Timo Hyypiä; Olli Ruuskanen; Matti Waris
Journal:  J Clin Virol       Date:  2011-02-20       Impact factor: 3.168

Review 6.  Newly identified human rhinoviruses: molecular methods heat up the cold viruses.

Authors:  Katherine E Arden; Ian M Mackay
Journal:  Rev Med Virol       Date:  2010-05       Impact factor: 6.989

Review 7.  Exploring the potential of foodborne transmission of respiratory viruses.

Authors:  Bridget O'Brien; Lawrence Goodridge; Jennifer Ronholm; Neda Nasheri
Journal:  Food Microbiol       Date:  2020-12-02       Impact factor: 5.516

8.  Phylogenetic analysis of human rhinoviruses collected over four successive years in Sydney, Australia.

Authors:  Vigneswary M Ratnamohan; Frank Zeng; Linda Donovan; Chandini R MacIntyre; Jen Kok; Dominic E Dwyer
Journal:  Influenza Other Respir Viruses       Date:  2016-08-09       Impact factor: 4.380

9.  Molecular characterization and distinguishing features of a novel human rhinovirus (HRV) C, HRVC-QCE, detected in children with fever, cough and wheeze during 2003.

Authors:  K E Arden; C E Faux; N T O'Neill; P McErlean; A Nitsche; S B Lambert; M D Nissen; T P Sloots; I M Mackay
Journal:  J Clin Virol       Date:  2010-01-27       Impact factor: 3.168

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.